ABVC Biopharma Current Valuation vs. Shares Outstanding
| ABVC Stock | USD 0.47 0.01 1.06% |
For ABVC Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ABVC Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ABVC Biopharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ABVC Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ABVC Biopharma over time as well as its relative position and ranking within its peers.
ABVC |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share 0.017 | Quarterly Revenue Growth 18.175 | Return On Assets (0.45) | Return On Equity (3.20) |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ABVC Biopharma Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining ABVC Biopharma's current stock value. Our valuation model uses many indicators to compare ABVC Biopharma value to that of its competitors to determine the firm's financial worth. ABVC Biopharma is rated below average in current valuation category among its peers. It also is rated below average in shares outstanding category among its peers creating about 1.48 of Shares Outstanding per Current Valuation. The current year's Common Stock Shares Outstanding is expected to grow to about 4.6 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABVC Biopharma's earnings, one of the primary drivers of an investment's value.ABVC Current Valuation vs. Competition
ABVC Biopharma is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 9.75 Billion. ABVC Biopharma adds roughly 8.25 Million in current valuation claiming only tiny portion of equities under Health Care industry.
ABVC Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
ABVC Biopharma |
| = | 8.25 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
ABVC Biopharma |
| = | 12.24 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
ABVC Shares Outstanding Comparison
ABVC Biopharma is currently under evaluation in shares outstanding category among its peers.
ABVC Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in ABVC Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ABVC Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of ABVC Biopharma's change in net profit over the period of time. It can combine multiple indicators of ABVC Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 516.4 K | 396.8 K | |
| Operating Income | -8.2 M | -7.8 M | |
| Income Before Tax | -10.7 M | -10.1 M | |
| Net Loss | -10.5 M | -10 M | |
| Total Other Income Expense Net | -2.4 M | -2.3 M | |
| Income Tax Expense | 256 K | 268.8 K | |
| Net Loss | -10.9 M | -11.5 M | |
| Net Loss | -14.8 M | -14 M | |
| Net Interest Income | -2.3 M | -2.2 M | |
| Interest Income | 185.5 K | 194.8 K | |
| Change To Netincome | 7.9 M | 8.3 M | |
| Net Loss | (2.43) | (2.55) | |
| Income Quality | 0.40 | 0.42 | |
| Net Income Per E B T | 0.99 | 1.17 |
ABVC Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on ABVC Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ABVC Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ABVC Biopharma's important profitability drivers and their relationship over time.
Use ABVC Biopharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABVC Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will appreciate offsetting losses from the drop in the long position's value.ABVC Biopharma Pair Trading
ABVC Biopharma Pair Trading Analysis
The ability to find closely correlated positions to ABVC Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABVC Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABVC Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABVC Biopharma to buy it.
The correlation of ABVC Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABVC Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABVC Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABVC Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your ABVC Biopharma position
In addition to having ABVC Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cannabis Thematic Idea Now
Cannabis
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
To fully project ABVC Biopharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ABVC Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ABVC Biopharma's income statement, its balance sheet, and the statement of cash flows.